Biotech IPOs Outperform AI Listings, Leading US Market in 2026

The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.

Originally published on www.bloomberg.com — View original

By

Leave a Reply

Your email address will not be published. Required fields are marked *